Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.400
+0.080 (1.85%)
Jan 21, 2025, 4:00 PM EST - Market closed
Biodexa Pharmaceuticals Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -6.82 | -7.08 | -7.66 | -5.46 | -22.19 | -10.09 | Upgrade
|
| Depreciation & Amortization | 0.28 | 0.28 | 0.34 | 0.4 | 1.22 | 1.29 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | 0.01 | -0.04 | -0.23 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 12.37 | - | Upgrade
|
| Stock-Based Compensation | 0.16 | 0.03 | 0.12 | 0.09 | -0.4 | -0.03 | Upgrade
|
| Other Operating Activities | -0.33 | -0.09 | -0.6 | -0.38 | 1.49 | -0.4 | Upgrade
|
| Change in Accounts Receivable | -1.04 | 0.37 | 0.01 | -0.49 | 0.49 | 0.73 | Upgrade
|
| Change in Accounts Payable | -0.09 | -0.21 | 0.36 | -0.13 | -2 | 1.14 | Upgrade
|
| Change in Other Net Operating Assets | - | -0.21 | 0.16 | - | -0.05 | -0.07 | Upgrade
|
| Operating Cash Flow | -7.75 | -6.83 | -7.05 | -6.01 | -9.3 | -6.49 | Upgrade
|
| Capital Expenditures | -0.02 | -0.03 | -0.06 | -0.32 | -0.21 | -0.31 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | 0.02 | 0.04 | 0.14 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.09 | -0.24 | - | - | - | -0.01 | Upgrade
|
| Other Investing Activities | 0.15 | 0.07 | 0.03 | - | 2.64 | -3.49 | Upgrade
|
| Investing Cash Flow | -1.04 | -0.27 | -0.22 | -0.28 | 2.57 | -3.81 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.05 | 4.54 | Upgrade
|
| Long-Term Debt Repaid | - | -0.19 | -0.18 | -0.22 | -6.44 | -1.03 | Upgrade
|
| Net Debt Issued (Repaid) | -0.19 | -0.19 | -0.18 | -0.22 | -6.4 | 3.52 | Upgrade
|
| Issuance of Common Stock | 10.47 | 12.08 | 0.32 | 10.09 | 10.79 | 15.77 | Upgrade
|
| Other Financing Activities | -1.66 | -1.67 | -0.1 | -1.07 | -1.31 | -0.55 | Upgrade
|
| Financing Cash Flow | 8.62 | 10.23 | 0.05 | 8.81 | 3.08 | 18.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0.01 | 0.26 | 0.15 | Upgrade
|
| Net Cash Flow | -0.17 | 3.14 | -7.22 | 2.51 | -3.38 | 8.59 | Upgrade
|
| Free Cash Flow | -7.77 | -6.85 | -7.11 | -6.33 | -9.51 | -6.8 | Upgrade
|
| Free Cash Flow Margin | -9366.27% | -1798.43% | -1017.17% | -1094.81% | -2772.59% | -1008.75% | Upgrade
|
| Free Cash Flow Per Share | -40.77 | -216.94 | - | - | - | - | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Cash Income Tax Paid | - | -0.85 | -0.68 | -1.16 | -1.95 | -1.92 | Upgrade
|
| Levered Free Cash Flow | -4.07 | 0.35 | -4.47 | -5.3 | -7.54 | -2.61 | Upgrade
|
| Unlevered Free Cash Flow | -4.03 | 0.37 | -4.43 | -5.27 | -7.52 | -2.55 | Upgrade
|
| Change in Net Working Capital | -0.76 | -4.45 | 0.1 | 1.07 | 1.39 | -3.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.